1.
Bettuzzi T, Bachelez H, Beylot-Barry M, Arlégui H, Paul C, Viguier M, Mahé E, Beneton N, Jullien D, Richard M-A, Joly P, Tubach F, Dupuy A, Sbidian E, Chosidow O. Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort. Acta Derm Venereol [Internet]. 2022 Mar. 8 [cited 2024 Mar. 29];102:adv00665. Available from: https://medicaljournalssweden.se/actadv/article/view/566